These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3070082)

  • 1. [Role of laboratory tests and imagings on the screening of pancreatic cancer].
    Yamamoto M; Ishida T; Ohyanagi H; Saitoh Y
    Rinsho Byori; 1988 Jul; 36(7):767-74. PubMed ID: 3070082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems in laboratory diagnosis of pancreatic diseases--reevaluation of screening strategies from laboratory medicine].
    Miyake K
    Rinsho Byori; 1991 Jun; Suppl 89():16-23. PubMed ID: 1716704
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor markers in pancreatic cancer--current concepts.
    Schmiegel W
    Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Definition, diagnosis and treatment of early pancreatic cancer].
    Tsunoda T; Kohara N; Tsuchiya R
    Nihon Rinsho; 1989 May; 47(5):1114-20. PubMed ID: 2664272
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of screening for carcinoma of the pancreas].
    Amikura K; Kobari M; Matsuno S
    Nihon Rinsho; 1996 May; 54(5):1431-4. PubMed ID: 8965380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis.
    Malesci A; Evangelista A; Mariani A; Bersani M; Bonato C; Basilico M; Montorsi M; Beretta E
    Int J Pancreatol; 1988; 3 Suppl 1():S119-23. PubMed ID: 3209865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor marker--personal experience. Mass survey and outpatients screening of pancreatic cancer].
    Homma T
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):497-501. PubMed ID: 2003745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer.
    David L; Carneiro F; Sobrinho-Simões M
    Cancer; 1996 Jul; 78(1):177-8. PubMed ID: 8646715
    [No Abstract]   [Full Text] [Related]  

  • 9. [CA 15.3, a marker of breast cancer].
    Ruibal A
    Med Clin (Barc); 1988 Sep; 91(9):341-3. PubMed ID: 3216756
    [No Abstract]   [Full Text] [Related]  

  • 10. Tn antigens and their significance in oncology.
    Lisowska E
    Acta Biochim Pol; 1995; 42(1):11-7. PubMed ID: 7653152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Developing a hospital-based high risk scoring model and screening strategy for pancreatic cancer].
    Deng RX; Lu XH; Wang L; Li H; Qian JM; Yang AM; Zhong SX; Guo XZ; Zhou L; Wu X; Yang XO; Jiang WJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2038-42. PubMed ID: 16313796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early detection of pancreatic cancer].
    Ishida T; Nakaizumi A; Tanaka S; Tatsuta M
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():155-9. PubMed ID: 16457240
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cancer-associated carbohydrate antigens in digestive cancers].
    Sawabu N; Kawakami H; Watanabe H; Satomura Y
    Rinsho Byori; 1989 May; 37(5):509-16. PubMed ID: 2770006
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A trial of the mass examination of pancreatic cancer using measurement of serum CA 19-9 and elastase-1 and ultrasonography].
    Hayashi S; Takebe T; Ohyama K; Odake Y; Takiyama Y; Koike D; Miyakawa H; Moriai T; Yamadera K; Myoen R
    Nihon Shokakibyo Gakkai Zasshi; 1986 Jul; 83(7):1360-6. PubMed ID: 3537394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immuno-proteomic screening of human pancreatic cancer associated membrane antigens for early diagnosis].
    Ning L; Pan B; Zhao YP; Liao Q; Zhang TP; Chen G; Wang WB; Yang YC
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):34-8. PubMed ID: 17403287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic diagnosis of cancer--tumor markers].
    Kawai T
    Gan No Rinsho; 1989 Jan; Spec No():13-8. PubMed ID: 2915470
    [No Abstract]   [Full Text] [Related]  

  • 18. [SC6 antigen for the diagnosis of pancreatic cancer before operation].
    Guo XZ; Liu ZF; Ai R
    Zhonghua Yi Xue Za Zhi; 1993 Jan; 73(1):26-8, 61-2. PubMed ID: 8389232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of present tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
    Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
    Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.